Homocysteine, glycine betaine, and N,N-Dimethylglycine (cas 1118-68-9) in patients attending a lipid clinic
-
Add time:09/29/2019 Source:sciencedirect.com
We recruited nondiabetic subjects (n = 158) attending a lipid disorders clinic, a subset of whom (n = 46) had established cardiovascular disease. Glycine betaine, N,N-Dimethylglycine (cas 1118-68-9), and carnitine were measured in fasting plasma and urine samples. The concentrations and excretions were related to known cardiovascular risk factors in multivariate regression models. The relationships between homocysteine and plasma and urinary glycine betaine were highly significant (P < .002), comparable with the known relationships with folate and plasma creatinine. The regression coefficient for plasma glycine betaine was consistently approximately −0.1 in 5 different regression models (3 best-subsets and forward and backward stepwise regression models) for predicting homocysteine using 23 variables. Plasma glycine betaine was higher in males than in females, and the difference was associated with a difference in percentage of body fat. Its concentration included a constant factor of approximately 20 μmol/L that was independent of any of the variables investigated here. In the total group, body fat, homocysteine, and carnitine were significant predictors of plasma glycine betaine. Carnitine, an important betaine that is involved in lipid metabolism positively correlated with both homocysteine and glycine betaine. In our sample, the urinary excretion of glycine betaine was outside the reference range in 14 of the 158 subjects and the betaine fractional clearances were above the reference range in 23 subjects. Fractional clearance correlated strongly with plasma homocysteine (r = 0.50), and this relationship may be stronger in patients with known vascular disease. Urinary loss of glycine betaine may contribute to hyperhomocysteinemia and the development of cardiovascular disease.
We also recommend Trading Suppliers and Manufacturers of N,N-Dimethylglycine (cas 1118-68-9). Pls Click Website Link as below: cas 1118-68-9 suppliers
Prev:Serum betaine, N,N-Dimethylglycine (cas 1118-68-9) and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism☆
Next:Brief communicationPrevention of strychnine-induced seizures and death by the N-methylated glycine derivatives betaine, dimethylglycine and sarcosine) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Brief communicationPrevention of strychnine-induced seizures and death by the N-methylated glycine derivatives betaine, dimethylglycine and sarcosine09/30/2019
- Serum betaine, N,N-Dimethylglycine (cas 1118-68-9) and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism☆09/28/2019
- Theoretical studies on the gas phase tautomerization of N,N-Dimethylglycine (cas 1118-68-9)10/01/2019
- Conformational analysis of N-methylglycine and N,N-Dimethylglycine (cas 1118-68-9) by ab initio calculations09/27/2019
- Gas chromatographic assay for N,N-Dimethylglycine (cas 1118-68-9) in urine09/26/2019
- Simultaneous determination of betaine and N,N-Dimethylglycine (cas 1118-68-9) in urine09/25/2019
- A theoretical investigation of the dictating forces in small amino acid conformational preferences: The case of glycine, sarcosine and N,N-Dimethylglycine (cas 1118-68-9)09/24/2019
- N,N-Dimethylglycine (cas 1118-68-9) differentially modulates psychotomimetic and antidepressant-like effects of ketamine in mice09/10/2019
- CuI/N,N-Dimethylglycine (cas 1118-68-9)-catalyzed synthesis of N-aryloxazolidinones from aryl bromides09/09/2019